Airlift Bioreactors Market Size Worth $ 9.58 Billion By 2032 | CAGR: 6.4%

Airlift Bioreactors Market Size Worth $ 9.58 Billion By 2032 | CAGR: 6.4%

The global airlift bioreactors market size is expected to reach USD 9.58 billion by 2032, according to a new study by Polaris Market Research. The report “Airlift Bioreactors Market Share, Size, Trends, Industry Analysis Report, By Product (Internal Airlift Loop Bioreactor and External Airlift Loop Bioreactor); By Capacity; By Material; By Usage; By End Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing demand for enhanced railway safety, increased transportation efficiency, and improved passenger experience drive the adoption of CBTC systems worldwide. These systems offer benefits such as reduced headways between trains, optimized train operations, improved punctuality, and enhanced passenger safety.

The CBTC system market is witnessing significant growth as railways and transit authorities seek modernization and upgrade their train control systems. This market includes various solution providers, system integrators, and equipment manufacturers who offer CBTC systems tailored to specific project requirements.

The era of bioprocessing 4.0 is improving the many technologies in the market. It is dynamically focusing on various systems and data connectivity in the biotech sectors. Likewise, automation, smart connected systems, and many other technologies are bringing loads of opportunities for the leading players in the market.

For example, one airlift bioreactor company forecasted that flexible automation would cut the project effort to start a bio-processing facility by around 50-75 percent since the integration significantly reduces activities. Such innovations in bio-processing technologies have improved performance, increased productivity, and decreased operational costs, making airlift bioreactors a critical option in biotechnology and pharmaceutical applications.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

The augmenting demand for bio-based products, such as biofuels, bioplastics, and biochemicals, propels the need for efficient and cost-effective bioreactor systems. Airlift bioreactors offer advantages in terms of improved mass transfer, enhanced oxygen transfer rates, and reduced energy consumption, making them attractive for the production of bio-based products. Besides, the biopharmaceutical industry, including the production of therapeutic proteins, antibodies, and vaccines, is experiencing substantial expansion in the global market. The surge in drug discovery and growing preference towards biopharma and biologics is also considered a vital contributor to the market's growth.

Airlift Bioreactors Market Report Highlights

  • In 2022, the internal airlift loop bioreactors segment held the largest market share as they provide better mixing and mass transfer than other bioreactors.
  • In 2022, the 30L segment held the fastest market share as these are employed in industrial-scale bioprocessing and production facilities.
  • In 2022, the biopharmaceutical companies segment held a significant market share in volume and value due to involvement in large-scale production of bio-pharmaceuticals
  • 2022 North America accounted for the largest airlift bioreactors market share, owing to the robust biopharmaceutical industry and many leading biotechnology companies.
  • The global players include Cellexus, Sartorius, Lonza, Electrolab Biotech, Shree Biocare, Rotech, Knik Technology, Solida Biotech, Zeta, and Kuhner Shaker.

Polaris Market Research has segmented the Airlift Bioreactors market report based on product, capacity, material, usage, end use, and region:

Airlift Bioreactors, Product Outlook (Revenue - USD Billion, 2019-2032)

  • Internal Airlift Loop Bioreactor
  • External Airlift Loop Bioreactor

Airlift Bioreactors, Capacity Outlook (Revenue - USD Billion, 2019-2032)

  • 5L
  • 7L
  • 10L
  • 30L

Airlift Bioreactors, Material Outlook (Revenue - USD Billion, 2019-2032)

  • Stainless Steel
  • Glass

Airlift Bioreactors, Usage Outlook (Revenue - USD Billion, 2019-2032)

  • Single-Use / Disposal
  • Reusable

Airlift Bioreactors, End Use Outlook (Revenue - USD Billion, 2019-2032)

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROS)/ Contract Development And Manufacturing Organizations (CDMOS)
  • Research and Development Companies

Airlift Bioreactors, Regional Outlook (Revenue - USD Billion, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Airlift Bioreactors Market Report Scope

Report Attributes


Market size value in 2023

USD 5.46 billion

Revenue forecast in 2032

USD 9.58 billion


6.4% from 2023 – 2032

Base year


Historical data

2019– 2021

Forecast period

2023– 2032

Quantitative units

Revenue in USD million/billion and CAGR from 2023 to 2032

Segments covered

By Product, By Capacity, By Material, By Usage, By End Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

Cellexus, Sartorius, Lonza, Electrolab Biotech, Shree Biocare, Rotech, Knik Technology, Solida Biotech, Zeta, and Kuhner shaker

For Specific Research Requirements

Request for Customized Report